The importance of protein biomarkers in drug development: A roundtable discussion
Speakers: Katerina Pardali, Senior Scientific Director<br>AM-Pharma</p>, Michael D. Howell, Co-Founder<br>Galileo Biosystems and Mountaineer Biosciences</p>, Magnus Althage, Director | Head of Translational Strategy team Translational Science & Experimental Medicine Early Cardiovascular, Renal and Metabolism Biopharmaceuticals<br>AstraZeneca</p>, Blake Forman, SelectScienceKaterina Pardali, Senior Scientific Director<br>AM-Pharma</p> · Michael D. Howell, Co-Founder<br>Galileo Biosystems and Mountaineer Biosciences</p> · Magnus Althage, Director | Head of Translational Strategy team Translational Science & Experimental Medicine Early Cardiovascular, Renal and Metabolism Biopharmaceuticals<br>AstraZeneca</p> · Blake Forman, SelectScienceKaterina Pardali, Senior Scientific Director<br>AM-Pharma</p>Michael D. Howell, Co-Founder<br>Galileo Biosystems and Mountaineer Biosciences</p>Magnus Althage, Director | Head of Translational Strategy team Translational Science & Experimental Medicine Early Cardiovascular, Renal and Metabolism Biopharmaceuticals<br>AstraZeneca</p>Blake Forman, SelectScience · · +1 more · +2 more · +3 more · +4 more
Watch on demand
